New treatment option for Renal Transplant
Official title Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney Transplantation
ClinicalTrials.gov ID: NCT06288152
What this study is testing
What is Sodium Thiosulfate?
Sodium Thiosulfate is an investigational medicine, being studied as a potential treatment for renal transplant.
Also referred to as Seacalphyx.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- End-stage renal disease (ESRD) is a significant clinical problem for which dialysis or transplantation is required. The current need for kidneys for transplantation vastly exceeds the supply available from live donors, necessitating the use of kidneys from deceased donors.
- Time commitment: about 24 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age and over
- End-Stage Renal Disease
- Receiving a kidney transplant from a deceased donor (NDD or DCD)
You likely can't join if
- Under 18 years of age
- Inability to provide informed consent
- Living donor kidney recipients
- Pregnant individuals
- Known allergy to study medication or its components (non-medicinal ingredients)
- Multiorgan transplant patients such as simultaneous kidney pancreas or liver kidney transplants
See the full eligibility criteria
- 18 years of age and over
- End-Stage Renal Disease
- Receiving a kidney transplant from a deceased donor (NDD or DCD)
- Under 18 years of age
- Inability to provide informed consent
- Living donor kidney recipients
- Pregnant individuals
- Known allergy to study medication or its components (non-medicinal ingredients)
- Multiorgan transplant patients such as simultaneous kidney pancreas or liver kidney transplants
- Currently enrolled in another treatment transplant clinical trial, or another clinical trial that in the opinion of the QI and PI would greatly impact the results of this study.
The study team makes the final eligibility decision.
Where it's taking place
- London, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 24 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.